ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the recommended phase II dose, and to assess the
safety of acelarin in combination with cisplatin in patients with locally advanced/
metastatic biliary tract cancers.